Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25


Nonunion of the Capitate due to Delayed Diagnosis of an Isolated Fracture: A Case Report.

Ochen Y, Emmink BL, Kootstra TJM, Bosman WM, Wittich P, Keizer J.

JBJS Case Connect. 2019 Oct 8. doi: 10.2106/JBJS.CC.18.00382. [Epub ahead of print]


Intramedullary screw fixation for simple displaced olecranon fractures.

Bosman WPF, Emmink BL, Bhashyam AR, Houwert RM, Keizer J.

Eur J Trauma Emerg Surg. 2019 Mar 16. doi: 10.1007/s00068-019-01114-4. [Epub ahead of print]


Intramedullary Fixation Versus Plate Fixation of Distal Fibular Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies.

Tas DB, Smeeing DPJ, Emmink BL, Govaert GAM, Hietbrink F, Leenen LPH, Houwert RM.

J Foot Ankle Surg. 2019 Jan;58(1):119-126. doi: 10.1053/j.jfas.2018.08.028.


[Complete triceps tendon rupture; a rare tendon injury].

Nawijn F, Emmink BL, Keizer J, Bosman WMPF.

Ned Tijdschr Geneeskd. 2018 Nov 2;162. pii: D2744. Dutch.


Paediatric forearm fracture with a twist: a proximal radioulnar translocation combined with radial head fracture.

Nawijn F, Emmink BL, Keizer J, Bosman WM.

BMJ Case Rep. 2018 Mar 28;2018. pii: bcr-2017-223228. doi: 10.1136/bcr-2017-223228.


ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer.

Trumpi K, Emmink BL, Prins AM, van Oijen MG, van Diest PJ, Punt CJ, Koopman M, Kranenburg O, Rinkes IH.

J Cancer. 2015 Sep 3;6(11):1079-86. doi: 10.7150/jca.12606. eCollection 2015.


SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer.

Vellinga TT, Borovski T, de Boer VC, Fatrai S, van Schelven S, Trumpi K, Verheem A, Snoeren N, Emmink BL, Koster J, Rinkes IH, Kranenburg O.

Clin Cancer Res. 2015 Jun 15;21(12):2870-9. doi: 10.1158/1078-0432.CCR-14-2290. Epub 2015 Mar 16.


Wnt signalling induces accumulation of phosphorylated β-catenin in two distinct cytosolic complexes.

Gerlach JP, Emmink BL, Nojima H, Kranenburg O, Maurice MM.

Open Biol. 2014 Nov;4(11):140120. doi: 10.1098/rsob.140120.


GPx2 suppression of H2O2 stress links the formation of differentiated tumor mass to metastatic capacity in colorectal cancer.

Emmink BL, Laoukili J, Kipp AP, Koster J, Govaert KM, Fatrai S, Verheem A, Steller EJ, Brigelius-Flohé R, Jimenez CR, Borel Rinkes IH, Kranenburg O.

Cancer Res. 2014 Nov 15;74(22):6717-30. doi: 10.1158/0008-5472.CAN-14-1645. Epub 2014 Sep 26.


Recurrence location after resection of colorectal liver metastases influences prognosis.

Govaert KM, van Kessel CS, Steller EJ, Emmink BL, Molenaar IQ, Kranenburg O, van Hillegersberg R, Borel Rinkes IH.

J Gastrointest Surg. 2014 May;18(5):952-60. doi: 10.1007/s11605-014-2461-0. Epub 2014 Jan 29.


Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells.

Govaert KM, Emmink BL, Nijkamp MW, Cheung ZJ, Steller EJ, Fatrai S, de Bruijn MT, Kranenburg O, Borel Rinkes IH.

Ann Surg. 2014 Apr;259(4):750-9. doi: 10.1097/SLA.0b013e318295c160.


Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.

Snoeren N, Emmink BL, Koerkamp MJ, van Hooff SR, Goos JA, van Houdt WJ, de Wit M, Prins AM, Piersma SR, Pham TV, Belt EJ, Bril H, Stockmann HB, Meijer GA, van Hillegersberg R, Holstege FC, Jimenez CR, Fijneman RJ, Kranenburg OW, Rinkes IH.

Br J Cancer. 2013 Sep 17;109(6):1636-47. doi: 10.1038/bjc.2013.489. Epub 2013 Sep 3.


The secretome of colon cancer stem cells contains drug-metabolizing enzymes.

Emmink BL, Verheem A, Van Houdt WJ, Steller EJ, Govaert KM, Pham TV, Piersma SR, Borel Rinkes IH, Jimenez CR, Kranenburg O.

J Proteomics. 2013 Oct 8;91:84-96. doi: 10.1016/j.jprot.2013.06.027. Epub 2013 Jul 5.


Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.

Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E, Yu M, Chen PI, Morgan B, Trautwein J, Kimura A, Sengupta S, Stott SL, Karabacak NM, Barber TA, Walsh JR, Smith K, Spuhler PS, Sullivan JP, Lee RJ, Ting DT, Luo X, Shaw AT, Bardia A, Sequist LV, Louis DN, Maheswaran S, Kapur R, Haber DA, Toner M.

Sci Transl Med. 2013 Apr 3;5(179):179ra47. doi: 10.1126/scitranslmed.3005616.


PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells.

Steller EJ, Raats DA, Koster J, Rutten B, Govaert KM, Emmink BL, Snoeren N, van Hooff SR, Holstege FC, Maas C, Borel Rinkes IH, Kranenburg O.

Neoplasia. 2013 Feb;15(2):204-17.


Proteomics in studying cancer stem cell biology.

Kranenburg O, Emmink BL, Knol J, van Houdt WJ, Rinkes IH, Jimenez CR.

Expert Rev Proteomics. 2012 Jun;9(3):325-36. doi: 10.1586/epr.12.24. Review.


Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation.

Govaert KM, Nijkamp MW, Emmink BL, Steller EJ, Minchinton AI, Kranenburg O, Borel Rinkes IH.

Br J Surg. 2012 Apr;99(4):567-75. doi: 10.1002/bjs.8668. Epub 2012 Feb 13.


Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.

Van Houdt WJ, Emmink BL, Pham TV, Piersma SR, Verheem A, Vries RG, Fratantoni SA, Pronk A, Clevers H, Borel Rinkes IH, Jimenez CR, Kranenburg O.

Mol Cell Proteomics. 2011 Dec;10(12):M111.011353. doi: 10.1074/mcp.M111.011353. Epub 2011 Jul 25.


The death receptor CD95 activates the cofilin pathway to stimulate tumour cell invasion.

Steller EJ, Ritsma L, Raats DA, Hoogwater FJ, Emmink BL, Govaert KM, Laoukili J, Rinkes IH, van Rheenen J, Kranenburg O.

EMBO Rep. 2011 Sep 1;12(9):931-7. doi: 10.1038/embor.2011.129.


Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737.

Raats DA, de Bruijn MT, Steller EJ, Emmink BL, Borel-Rinkes IH, Kranenburg O.

Cell Oncol (Dordr). 2011 Aug;34(4):307-13. doi: 10.1007/s13402-011-0026-8. Epub 2011 Apr 6.


Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.

Emmink BL, Van Houdt WJ, Vries RG, Hoogwater FJ, Govaert KM, Verheem A, Nijkamp MW, Steller EJ, Jimenez CR, Clevers H, Borel Rinkes IH, Kranenburg O.

Gastroenterology. 2011 Jul;141(1):269-78. doi: 10.1053/j.gastro.2011.03.052. Epub 2011 Apr 1.


Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation.

van Houdt WJ, Hoogwater FJ, de Bruijn MT, Emmink BL, Nijkamp MW, Raats DA, van der Groep P, van Diest P, Borel Rinkes IH, Kranenburg O.

Neoplasia. 2010 Jun;12(6):443-52.


Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.

van Houdt WJ, de Bruijn MT, Emmink BL, Raats D, Hoogwater FJ, Borel Rinkes IH, Kranenburg O.

Cell Oncol. 2010 Jan 1;32(4):245-57. doi: 10.3233/CLO-2010-0521.


Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells.

Hoogwater FJ, Nijkamp MW, Smakman N, Steller EJ, Emmink BL, Westendorp BF, Raats DA, Sprick MR, Schaefer U, Van Houdt WJ, De Bruijn MT, Schackmann RC, Derksen PW, Medema JP, Walczak H, Borel Rinkes IH, Kranenburg O.

Gastroenterology. 2010 Jun;138(7):2357-67. doi: 10.1053/j.gastro.2010.02.046. Epub 2010 Feb 23.


Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles.

van Houdt WJ, Smakman N, van den Wollenberg DJ, Emmink BL, Veenendaal LM, van Diest PJ, Hoeben RC, Borel Rinkes IH, Kranenburg O.

Cancer Gene Ther. 2008 May;15(5):284-92. doi: 10.1038/cgt.2008.2. Epub 2008 Feb 8.


Supplemental Content

Loading ...
Support Center